Tropisetron: Optimal dosage for children in prevention of chemotherapy-induced vomiting

Pediatric Blood and Cancer

Volumn 45, Issue 1, 2005, Pages 48-53

  Cappelli, Carlo ^a   Ragni, Giuseppina ^a   De Pasquale, Maria Debora ^a   Gonfiantini, Michaela ^a   Russo, Daria ^a   Clerico, Anna ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Antiemetic therapy; Chemotherapy; Children; Tropisetron

Indexed keywords

AMSACRINE; ANTINEOPLASTIC AGENT; ASPARAGINASE; BLEOMYCIN; BUSULFAN; CARBOPLATIN; CARMUSTINE; CHLORAMBUCIL; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DACTINOMYCIN; DAUNORUBICIN; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETHIONAMIDE; ETOPOSIDE; FLUDARABINE; FLUOROURACIL; FOTEMUSTINE; GEMCITABINE; HYDROXYUREA; IDARUBICIN; IFOSFAMIDE; IRINOTECAN; LOMUSTINE; MELPHALAN; MERCAPTOPURINE; METHOTREXATE; MITOGUAZONE; MITOMYCIN; MITOXANTRONE; NAVELBINE; PACLITAXEL; PREDNISONE; PROCARBAZINE; SEROTONIN ANTAGONIST; STREPTOZOCIN; THIOTEPA; TIOGUANINE; TOPOTECAN; TROPISETRON; VINBLASTINE; VINCRISTINE;

ARTICLE; CANCER CHEMOTHERAPY; CHEMOTHERAPY INDUCED EMESIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; DRUG TOLERABILITY; HUMAN; PRIORITY JOURNAL; SIDE EFFECT; SINGLE DRUG DOSE; SOLID TUMOR; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; ANTIEMETICS; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INDOLES; INFANT; INFUSIONS, INTRAVENOUS; MALE; VOMITING;

EID: 20344408279     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20182     Document Type: Article

References (26)

1. Dick GS, Meller ST, Pinkerton CR. Randomised comparison of Ondansetron and Metoclopramide plus Dexamethasone for chemotherapy-induced emesis. Arch Dis Child 1995;73:243-245.
2. Sledge GW, Jr., Einhorn L, Nagy C, et al. Phase III double-blind comparison of intravenous Ondansetron and Metoclopramide as antiemetic therapy for patients receiving multiple-day Cisplatin-based chemotherapy. Cancer 1992;15:2524-2528.
3. Polubiec A, Krasnopolska-Polanczky Z, Duda-Krol W, et al. Evaluation of antiemetic effect of Domperidon in patients treated with cytostatic drugs. Ther Hung 1992;40:169-172.
4. Olver IN, Wolf M, Laidlaw C, et al. Randomized double-blind study of high-dose Metoclopramide as antiemetic for cancer chemotherapy. Eur J Cancer 1992;28:1798-1802.
5. Hesketh PJ, Kris MG, Grunberg SM, et al. Proposal for classifying the acute emetogenicity of cancer chemotherapy. J Clin Oncol 1997;15:103-109.
6. Roila F, Tonato M, Ballatori E, et al. Metodologia degli studi di terapia antiemetica. Acta Oncol 1992;13:385-392.
7. Suarez A, Stettler ER, Rey E, et al. Safety, tolerability, efficacy and plasma concentrations of tropisetron after administration at five dose levels to children receiving cancer chemotherapy. Eur J Cancer 1994;30:1436-1441.
8. Bleiberg H, Van Belle S, Paridaens R, et al. Compassionate use of tropisetron in patients at high risk of severe emesis. Ann Oncol 1993;4:43-45.
9. Erttmann R, Gaedicke G, Henze G, et al. Phase I study of tropisetron in children. Proc Am Soc Clin Oncol 1994;13:462 (abs.1605).
10. Benoit Y, Hulstaert F, Vermylen C, et al. Control of nausea and vomiting by Navoban (tropisetron) in 131 children receiving cytotoxic chemotherapy. Anticancer Drugs 1995;6:9-14.
11. Cefalo G, Rottoli L, Armiraglio A, et al. Tropisetron in pediatric oncology: First result in patients refractory to antiemetic metoclopramide-based treatments. Am J Pediatric Hematol Oncol 1994;16:242-245.
12. Barberoglu S. Prevention of emesis by tropisetron in children receiving combined chemotherapy with cisplatin. Pediatr Hematol Oncol 1995;12:479-483.
13. Otten J, Hachimi-Idrissi S, Balduck N, et al. Prevention of emesis by tropisetron (navoban) in children receiving cytotoxic therapy for solid malignancies. Semin Oncol 1994;21:17-19.
14. Stiakaki E, Savvas E, Lydaki E, et al. Ondansetron and Tropisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy. Pediatr Hematol Oncol 1999;16:101-108.
15. Benoit Y, Vermylen C, Sariban E, et al. Proc Am Soc Clin Oncol 1994;13:430(abs.1477).
16. Gershanovich ML, Kolygin BA. Tropisetron (Navoban) in the prevention of nausea and vomiting induced by combined cancer chemotherapy in adults and children. Ann Oncol 1994;5:204 (abs.P1026).
17. Ozkan A, Yildiz I, Yuksel L, et al. Tropisetron (Navoban) in the control of nausea and vomiting induced by combined cancer chemotherapy in children. Jpn J Clin Oncol 1999;29:92-95.
18. Jurgens H, McQuade B. Ondansetron as prophylaxis for chemotherapy and radiotherapy-induced emesis in children. Oncology 1992;49:279-285.
19. Tsuchida Y, Hayashi Y, Asami K, et al. Effects of Granisetron in children undergoing high-dose chemotherapy: A multi-institutional, cross-over study. Int J Oncol 1999;14:673-679.
20. Miyajima Y, Numata S, Katayama I, et al. Prevention of chemotherapy-induced emesis with Granisetron in children with malignant diseases. Am J Pediatr Hematol Oncol 1994;16:236-241.
21. Aksoylar S, Akman SA, Ozgenc F, et al. Comparison of tropisetron and granisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy. Pediatr Hematol Oncol 2001;18:397-406.
22. Garcia del Muro X, Vadell C, Perez Manga G, et al. Randomized double-blind study comparing tropisetron alone and in combination with dexamethasone in the prevention of acute and delayed cisplatin-induced emesis. Eur J Cancer 1998;34:193-195.
23. Hewitt M, McQuade B, Stevens R. The efficacy and safety of Ondansetron in the prophylaxis of cancer chemotherapy-induced nausea and vomiting in children. Clin Oncol (R Coll Radiol) 1993;5:11-14.
24. Wymenga AN, van der Graaf WT, Wils JA, et al. A randomized, double-blind, multicentre study comparing daily 2 and 5 mg of tropisetron for the control of nausea and vomiting induced by low dose cisplatin or non-cisplatin-containing chemotherapy. Ann Oncol 1996;7:505-510.
25. Craft AW, Price L, Eden OB, et al. Granisetron as antiemetic therapy in children with cancer. Med Pediatr Oncol 1995;25:28-32.
26. Komada Y, Matsuyama T, Takao A, et al. A randomized dose-comparison trial of Granisetron in preventing emesis in children with leukaemia receiving emetogenic chemotherapy. Eur J Cancer 1999;35:1095-1101.